| Year |
Title |
Altmetric |
| 2018
|
Hydroxyproline metabolism and oxalate synthesis in primary hyperoxaluria.
Journal of the American Society of Nephrology.
29:1615-1623.
2018
|
|
| 2018
|
Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line.
Redox Biology.
15:207-215.
2018
|
|
| 2017
|
The L530R variation associated with recurrent kidney stones impairs the structure and function of TRPV5.
Biochemical and Biophysical Research Communications.
492:362-367.
2017
|
|
| 2017
|
Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass.
Gastroenterology.
152:1055-1067.e3.
2017
|
|
| 2017
|
An investigational RNAi therapeutic targeting glycolate oxidase reduces oxalate production in models of primary hyperoxaluria.
Journal of the American Society of Nephrology.
28:494-503.
2017
|
|
| 2016
|
RNA interference in the treatment of renal stone disease: Current status and future potentials.
International Journal of Surgery.
36:713-716.
2016
|
|
| 2016
|
Ascorbic acid intake and oxalate synthesis.
Urolithiasis.
44:289-297.
2016
|
|
| 2016
|
Monocyte Mitochondrial Function in Calcium Oxalate Stone Formers.
Urology.
93:224.e1-224.e6.
2016
|
|
| 2016
|
Effects of alanine: Glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.
BBA - Molecular Basis of Disease.
1862:1055-1062.
2016
|
|
| 2016
|
Oxalate Concentrations in Human Gastrointestinal Fluid.
Journal of Endourology and Part B, Videourology.
30:S8-S11.
2016
|
|
| 2016
|
Molecular Modeling of the Structural and Dynamical Changes in Calcium Channel TRPV5 Induced by the African-Specific A563T Variation.
Biochemistry.
55:1254-1264.
2016
|
|
| 2016
|
Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.
Urolithiasis.
44:27-32.
2016
|
|
| 2016
|
Metabolism of 13C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.
BBA - Molecular Basis of Disease.
1862:233-239.
2016
|
|
| 2016
|
Oxalate formation from glyoxal in erythrocytes.
Urology.
88:226.e11-226.e15.
2016
|
|
| 2015
|
Hydroxyproline metabolism in a mouse model of Primary Hyperoxaluria Type 3.
BBA - Molecular Basis of Disease.
1852:2700-2705.
2015
|
|
| 2015
|
Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria.
Biochemical Journal.
466:273-281.
2015
|
|
| 2015
|
A mutation creating an out-of-frame alternative translation initiation site in the GRHPR 5′UTR causing primary hyperoxaluria type II.
Clinical Genetics.
88:494-498.
2015
|
|
| 2012
|
Hydroxyproline metabolism in mouse models of primary hyperoxaluria.
AJP - Renal Physiology.
302.
2012
|
|
| 2012
|
Metabolism of [ 13C 5]hydroxyproline in vitro and in vivo: Implications for primary hyperoxaluria.
AJP - Gastrointestinal and Liver Physiology.
302.
2012
|
|
| 2012
|
The association of cardiovascular disease and metabolic syndrome with nephrolithiasis.
Current Opinion in Urology.
22:154-159.
2012
|
|
| 2012
|
Multibacterial growth from a surgical renal stone culture: a case report and literature review..
Reviews in Urology.
14:108-114.
2012
|
|
| 2011
|
Variability in urinary oxalate measurements between six international laboratories.
Nephrology Dialysis Transplantation.
26:3954-3959.
2011
|
|
| 2011
|
Difficulties with access in percutaneous renal surgery.
Journal of Endourology and Part B, Videourology.
25:1689-1690.
2011
|
|
| 2011
|
Re: Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers.
Journal of Urology, The.
186:1916-1917.
2011
|
|
| 2011
|
Impact of dietary calcium and oxalate, and oxalobacter formigenes colonization on urinary oxalate excretion.
Journal of Urology, The.
186:135-139.
2011
|
|
| 2011
|
Metabolism of primed, constant infusions of [1,2-13C 2] glycine and [1-13C1] phenylalanine to urinary oxalate.
Metabolism.
60:950-956.
2011
|
|
| 2011
|
Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers.
Urology.
78:475.e9-475.e13.
2011
|
|
| 2006
|
Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2.
Nephrology Dialysis Transplantation.
21:2292-2295.
2006
|
|
| 2005
|
Genetic and dietary factors in urinary citrate excretion.
Journal of Endourology and Part B, Videourology.
19:177-182.
2005
|
|
| 2005
|
Mitochondrial hydroxyproline metabolism: Implications for primary hyperoxaluria.
American Journal of Nephrology.
25:171-175.
2005
|
|
| 2005
|
Dietary oxalate loads and renal oxalate handling.
Journal of Urology, The.
174:943-947.
2005
|
|
| 2004
|
Glycolate and glyoxylate metabolism in HepG2 cells.
American Journal of Physiology - Cell Physiology.
287.
2004
|
|
| 2004
|
The impact of dietary oxalate on kidney stone formation.
Urological Research.
32:311-316.
2004
|
|
| 2001
|
(L)-2-oxothiazolidine-4-carboxylate in the treatment of primary hyperoxaluria type 1.
BJU International.
88:858-862.
2001
|
|
| 2001
|
Contribution of dietary oxalate to urinary oxalate excretion.
Kidney International.
59:270-276.
2001
|
|
| 2000
|
Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2).
Human Genetics.
107:176-185.
2000
|
|
| 2000
|
Role of diet in the therapy of urolithiasis.
Urologic Clinics of North America.
27:255-268.
2000
|
|
| 1997
|
Pathways of hepatic oxalate synthesis and their regulation.
American Journal of Physiology.
272.
1997
|
|
| 1997
|
Genes in idiopathic calcium oxalate stone disease.
World Journal of Urology.
15:186-194.
1997
|
|
| 1997
|
Pathways of hepatic oxalate synthesis and their regulation..
American Journal of Physiology.
272:C289-C294.
1997
|
|
| 1997
|
The effects of (L)-2-oxothiazolidine-4-carboxylate on urinary oxalate excretion.
Journal of Urology, The.
158:34-37.
1997
|
|
| 1996
|
Re: Family pattern of idiopathic hypercalciuria and its subtypes.
Journal of Urology, The.
156:2012.
1996
|
|
| 1995
|
Dietary oxalate and its intestinal absorption.
Scanning microscopy.
9:1109-1120.
1995
|
|
| 1995
|
Glucagon increases urinary oxalate excretion in the guinea pig..
American Journal of Physiology.
269:E568-E574.
1995
|
|
| 1995
|
Genetic Factors in Calcium Oxalate Stone Disease.
Journal of Urology, The.
153:301-307.
1995
|
|
| 1995
|
Glucagon increases urinary oxalate excretion in the guinea pig.
AJP - Endocrinology and Metabolism.
269.
1995
|
|
| 1995
|
Measurement of urinary oxalate and citrate by capillary electrophoresis and indirect ultraviolet absorbance.
Clinical Chemistry.
41:1297-1301.
1995
|
|
| 1993
|
The absence of glyxylate cycle enzymes in rodent and embryonic chick liver.
BBA - General Subjects.
1158:47-51.
1993
|
|
| 1993
|
Relationship of protein intake to urinary oxalate and glycolate excretion.
Kidney International.
44:366-372.
1993
|
|
| 1992
|
Recent developments in assays for taurine, hypotaurine and some metabolic precursors.
Advances in human genetics.
315:423-428.
1992
|
|
| 1992
|
Tetrodotoxin protects against acute ischemic renal failure in the rat.
Journal of Urology, The.
147:519-522.
1992
|
|
| 1989
|
Selective elevation of urinary enzyme levels after extracorporeal shock wave lithotripsy.
Journal of Urology, The.
142:687-690.
1989
|
|
| 1987
|
Failure of leukotriene B 4 to translocate calcium across phosphatidylcholine membranes.
Cell Calcium.
8:449-454.
1987
|
|
